目的:胃肠道疾病(GI)与心血管疾病(CVD)之间的关系尚不清楚。我们进行了一项前瞻性队列研究,以探讨它们的关联。
方法:本研究包括来自英国生物库队列的330.751名没有基线CVD的个体。对有和没有地理标志的个人进行跟踪,直到确定事件CVD,包括冠心病(CHD),脑血管疾病(CeVD),心力衰竭(HF)和外周动脉疾病(PAD)。结合全国住院数据证实了疾病的诊断,初级保健数据,和癌症登记处。多变量Cox比例风险回归模型用于评估GI与CVD事件风险之间的关联。
结果:在11.8年的中位随访期间,诊断为31.605例CVD事件。患有GI的个体患CVD的风险升高(风险比1.37;95%置信区间1.34-1.41,P<0.001)。15个GI中有11个与Bonferroni校正后CVD风险增加相关,包括肝硬化,非酒精性脂肪性肝病,胃炎和十二指肠炎,肠易激综合征,巴雷特食管,胃食管反流病,消化性溃疡,乳糜泻,憩室,阑尾炎,和胆道疾病。这些协会在女性中更强,年龄≤60岁的人,体重指数≥25kg/m2者。
结论:这项大规模前瞻性队列研究揭示了GI与心血管事件风险增加的关联,特别是CHD和PAD。这些发现支持在胃肠道疾病患者中加强二级CVD预防。
OBJECTIVE: The associations between gastrointestinal diseases (GIs) and cardiovascular disease (CVD) were unclear. We conducted a prospective cohort
study to explore their associations.
METHODS: This
study included 330 751 individuals without baseline CVD from the UK Biobank cohort. Individuals with and without GIs were followed up until the ascertainment of incident CVDs, including coronary heart disease (CHD), cerebrovascular disease (CeVD), heart failure (HF), and peripheral artery disease (PAD). The diagnosis of diseases was confirmed with combination of the nationwide inpatient data, primary care data, and cancer registries. A multivariable Cox proportional hazard regression model was used to estimate the associations between GIs and the risk of incident CVD.
RESULTS: During a median follow-up of 11.8 years, 31 605 incident CVD cases were diagnosed. Individuals with GIs had an elevated risk of CVD (hazard ratio 1.37; 95% confidence interval 1.34-1.41, P < 0.001). Eleven out of 15 GIs were associated with an increased risk of CVD after Bonferroni-correction, including cirrhosis, non-alcoholic fatty liver disease, gastritis and duodenitis, irritable bowel syndrome, Barrett\'s esophagus, gastroesophageal reflux disease, peptic ulcer, celiac disease, diverticulum, appendicitis, and biliary disease. The associations were stronger among women, individuals aged ≤60 years, and those with body mass index ≥25 kg/m2.
CONCLUSIONS: This large-scale prospective cohort
study revealed the associations of GIs with an increased risk of incident CVD, in particular CHD and PAD. These findings support the reinforced secondary CVD prevention among patients with gastrointestinal disorders.